| 1 | 1 | | IV |
|---|
| 2 | 2 | | 119THCONGRESS |
|---|
| 3 | 3 | | 1 |
|---|
| 4 | 4 | | STSESSION H. RES. 277 |
|---|
| 5 | 5 | | Supporting the designation of May 2025 as ‘‘National Myositis Awareness |
|---|
| 6 | 6 | | Month’’. |
|---|
| 7 | 7 | | IN THE HOUSE OF REPRESENTATIVES |
|---|
| 8 | 8 | | MARCH31, 2025 |
|---|
| 9 | 9 | | Mr. M |
|---|
| 10 | 10 | | CCORMICKsubmitted the following resolution; which was referred to the |
|---|
| 11 | 11 | | Committee on Energy and Commerce |
|---|
| 12 | 12 | | RESOLUTION |
|---|
| 13 | 13 | | Supporting the designation of May 2025 as ‘‘National |
|---|
| 14 | 14 | | Myositis Awareness Month’’. |
|---|
| 15 | 15 | | Whereas residents of the United States of America are |
|---|
| 16 | 16 | | among those affected by myositis and other rare diseases, |
|---|
| 17 | 17 | | with nearly 1 in 10 Americans having rare diseases; |
|---|
| 18 | 18 | | Whereas idiopathic inflammatory myopathies (collectively re- |
|---|
| 19 | 19 | | ferred to as myositis) are rare, chronic, autoimmune |
|---|
| 20 | 20 | | muscle-wasting diseases that often feature debilitating |
|---|
| 21 | 21 | | muscle inflammation and other symptoms, such as pain, |
|---|
| 22 | 22 | | fatigue, and trouble swallowing, and can result in myosi- |
|---|
| 23 | 23 | | tis-associated interstitial lung disease; |
|---|
| 24 | 24 | | Whereas more research is needed to identify the causes of |
|---|
| 25 | 25 | | and modes of treatments for the myositis group of dis- |
|---|
| 26 | 26 | | eases, which includes anti-MDA5 autoantibody-positive |
|---|
| 27 | 27 | | myositis, antisynthetase syndrome, dermatomyositis, juve- |
|---|
| 28 | 28 | | VerDate Sep 11 2014 02:54 Apr 01, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6300 E:\BILLS\HR277.IH HR277 |
|---|
| 29 | 29 | | ssavage on LAPJG3WLY3PROD with BILLS 2 |
|---|
| 30 | 30 | | •HRES 277 IH |
|---|
| 31 | 31 | | nile dermatomyositis, immune-mediated necrotizing my- |
|---|
| 32 | 32 | | opathy, inclusion body myositis, and polymyositis; |
|---|
| 33 | 33 | | Whereas myositis is difficult to diagnose which leads myositis |
|---|
| 34 | 34 | | patients to frequently experience delayed treatment and |
|---|
| 35 | 35 | | difficulty finding a health care provider with expertise in |
|---|
| 36 | 36 | | their condition; |
|---|
| 37 | 37 | | Whereas all who suffer with myositis experience reduced qual- |
|---|
| 38 | 38 | | ity of life, particularly since no cure has been found and |
|---|
| 39 | 39 | | life expectancy is shortened, especially for those with in- |
|---|
| 40 | 40 | | clusion body myositis, and women and people of color |
|---|
| 41 | 41 | | with all forms of myositis experience particularly pro- |
|---|
| 42 | 42 | | nounced health disparities; and |
|---|
| 43 | 43 | | Whereas public awareness and education campaigns on myo- |
|---|
| 44 | 44 | | sitis detection and treatment are held during the month |
|---|
| 45 | 45 | | of May: Now, therefore, be it |
|---|
| 46 | 46 | | Resolved, That the House of Representatives— 1 |
|---|
| 47 | 47 | | (1) supports the designation of ‘‘National Myo-2 |
|---|
| 48 | 48 | | sitis Awareness Month’’; 3 |
|---|
| 49 | 49 | | (2) recognizes the importance of raising aware-4 |
|---|
| 50 | 50 | | ness about myositis and its impact on United States 5 |
|---|
| 51 | 51 | | veterans and citizens; and 6 |
|---|
| 52 | 52 | | (3) encourages all people in the United States 7 |
|---|
| 53 | 53 | | to become more informed about myositis and to sup-8 |
|---|
| 54 | 54 | | port the individuals and families who are affected by 9 |
|---|
| 55 | 55 | | these conditions. 10 |
|---|
| 56 | 56 | | Æ |
|---|
| 57 | 57 | | VerDate Sep 11 2014 02:54 Apr 01, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6301 E:\BILLS\HR277.IH HR277 |
|---|
| 58 | 58 | | ssavage on LAPJG3WLY3PROD with BILLS |
|---|